Skip to content
Aussie8 – Lifestyle
Author:
HERVolution Therapeutics
HERVolution Therapeutics Demonstrates Preclinical Proof-of-Concept for Insulin Sensitization Immune Therapy in Metabolic Disease and Announces Exclusive License Agreement with the University of Copenhagen
June 10, 2026